Identifying Fibrillization State of Aβ Protein via Near-Field THz Conductance Measurement
- 13 March 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 14 (6) , 6548-6558
Abstract
Progressive Alzheimer’s disease is correlated with the oligomerization and fibrilization of the amyloid beta (Aβ) protein. We identify the fibrillization stage of the Aβ protein through label-free near-field THz conductance measurements in a buffer solution. Frequency-dependent conductance was obtained by measuring the differential transmittance of the time-domain spectroscopy in the THz range with a molar concentration of monomer, oligomer, and fibrillar forms of the Aβ protein. Conductance at the lower frequency limit was observed to be high in monomers, reduced in oligomers, and dropped to an insulating state in fibrils and increased proportionally with the Aβ protein concentration. The monotonic decrease in the conductance at low frequency was dominated by a simple Drude component in the monomer with concentration and nonlinear conductance behaviors in oligomer and fibril. By extracting the structural localization parameter, a dimensionless constant, with the modified Drude-Smith model, we defined a dementia quotient (DQ) value (0 < De < 1) as a discrete metric for a various Aβ proteins at a low concentration of 0.1 μmol/L; DQ = 1.0 ± 0.002 (fibril by full localization, mainly by Smith component), DQ = 0.64 ± 0.013 (oligomer by intermixed localization), and DQ = 0.0 ± 0.000 (monomer by Drude component). DQ values were discretely preserved independent of the molar concentration or buffer variation. This provides plenty of room for the label-free diagnosis of the Alzheimer’s disease using the near-field THz conductance measurement.Keywords
Funding Information
- Institute for Basic Science (IBS-R011-D1)
This publication has 56 references indexed in Scilit:
- The Amyloid-β Oligomer Hypothesis: Beginning of the Third DecadeJournal of Alzheimer’s Disease, 2018
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brainNature Reviews Neurology, 2017
- The amyloid hypothesis of Alzheimer's disease at 25 yearsEMBO Molecular Medicine, 2016
- Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer DiseaseThe American Journal of Pathology, 2016
- President Obama Announces the BRAIN InitiativeACS Nano, 2013
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Intracellular amyloid-β in Alzheimer's diseaseNature Reviews Neuroscience, 2007
- Effects of the monomeric, oligomeric, and fibrillar Aβ42 peptides on the proliferation and differentiation of adult neural stem cells from subventricular zoneJournal of Neurochemistry, 2007
- What Don't We Know?Science, 2005
- Protofibrils, the unifying toxic molecule of neurodegenerative disorders?Nature Neuroscience, 2001